Gluten-free diet - what is toxic?

被引:42
作者
Ciclitira, PJ
Ellis, HJ
Lundin, KEA
机构
[1] St Thomas Hosp, Rayne Inst, KCL, London SE1 7EH, England
[2] Natl Hosp Norway, Dept Med, N-0027 Oslo, Norway
[3] Natl Hosp Norway, Inst Immunol, N-0027 Oslo, Norway
关键词
gluten; coeliac disease; toxic effects; wheat; oats;
D O I
10.1016/j.bpg.2005.01.003
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The cornerstone of treatment of coeliac disease is a gluten-free diet devoid of proteins from wheat, rye, barley and related cereals. Oats are tolerated by most patients with coeliac disease but are not totally innocent. There are considerable differences between individual patients with respect to clinical and mucosal responses to gluten challenge. In vitro and in vivo testing has identified synthetic peptides that are toxic to the coeliac small intestinal mucosa. This toxicity overlaps at least partly to the known epitopes that are recognised by small intestinal T-cells. However, the clinical significance of several of these epitopes is unclear, as is the maximum level of gluten intake that can be recommended to be safe for patients with coeliac disease. Future efforts may lead to better understanding of the disease processes as well as possible new therapeutic options.
引用
收藏
页码:359 / 371
页数:13
相关论文
共 78 条
[1]   In vivo antigen challenge in celiac disease identifies a single transglutaminase-modified peptide as the dominant A-gliadin T-cell epitope [J].
Anderson, RP ;
Degano, P ;
Godkin, AJ ;
Jewell, DP ;
Hill, AVS .
NATURE MEDICINE, 2000, 6 (03) :337-342
[2]   The molecular basis for oat intolerance in patients with Celiac disease [J].
Arentz-Hansen, H ;
Fleckenstein, B ;
Molberg, O ;
Scott, H ;
Koning, F ;
Jung, G ;
Roepstorff, P ;
Lundin, KEA ;
Sollid, LM .
PLOS MEDICINE, 2004, 1 (01) :84-92
[3]   The intestinal T cell response to α-gliadin in adult celiac disease is focused on a single deamidated glutamine targeted by tissue transglutaminase [J].
Arentz-Hansen, H ;
Körner, R ;
Molberg, O ;
Quarsten, H ;
Vader, W ;
Kooy, YMC ;
Lundin, KEA ;
Koning, F ;
Roepstorff, P ;
Sollid, LM ;
McAdam, SN .
JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 191 (04) :603-612
[4]   Celiac lesion T cells recognize epitopes that cluster in regions of gliadins rich in proline residues [J].
Arentz-Hansen, H ;
McAdam, SN ;
Molberg, O ;
Fleckenstein, B ;
Lundin, KEA ;
Jorgensen, TJD ;
Jung, G ;
Roepstorff, P ;
Sollid, LM .
GASTROENTEROLOGY, 2002, 123 (03) :803-809
[5]  
Biagi F, 2004, NUTR REV, V62, P360, DOI [10.1301/nr.2004.sept.360-363, 10.1111/j.1753-4887.2004.tb00062.x]
[6]   ORGAN CULTURE OF MUCOSAL BIOPSIES OF HUMAN SMALL INTESTINE [J].
BROWNING, TH ;
TRIER, JS .
JOURNAL OF CLINICAL INVESTIGATION, 1969, 48 (08) :1423-+
[7]   Long-term follow-up of celiac adults on gluten-free diet: Prevalence and correlates of intestinal damage [J].
Ciacci, C ;
Cirillo, M ;
Cavallaro, R ;
Mazzacca, G .
DIGESTION, 2002, 66 (03) :178-185
[8]   CLINICAL-TESTING OF GLIADIN FRACTIONS IN CELIAC PATIENTS [J].
CICLITIRA, PJ ;
EVANS, DJ ;
FAGG, NLK ;
LENNOX, ES ;
DOWLING, RH .
CLINICAL SCIENCE, 1984, 66 (03) :357-364
[9]   The safe threshold for gluten contamination in gluten-free products.: Can trace amounts be accepted in the treatment of coeliac disease? [J].
Collin, P ;
Thorell, L ;
Kaukinen, K ;
Mäki, M .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2004, 19 (12) :1277-1283
[10]   INVITRO (ORGAN-CULTURE) STUDIES OF THE TOXICITY OF SPECIFIC A-GLIADIN PEPTIDES IN CELIAC-DISEASE [J].
DERITIS, G ;
AURICCHIO, S ;
JONES, HW ;
LEW, EJL ;
BERNARDIN, JE ;
KASARDA, DD .
GASTROENTEROLOGY, 1988, 94 (01) :41-49